A biotechnology drug developer focused on treatments for cancer, immune disorders, and inflammatory diseases. Its portfolio historically included blockbuster therapies such as Revlimid and Pomalyst for blood cancers, making the company a major player in oncology drug markets. Investors closely follo...
11 members of Congress have disclosed 50 trades in Celgene Corporation (CELG), a Healthcare company. The buy/sell breakdown shows 20 purchases versus 30 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-04-25 | Rohit Khanna | sell | $1K – $15K |
| 2021-02-19 | ALAN S. LOWENTHAL | sell | $15K – $50K |
| 2019-11-20 | Gilbert Cisneros | sell | $1K – $15K |
| 2019-10-01 | Pat Roberts | sell | $1K – $15K |
| 2019-03-14 | Gilbert Cisneros | buy | $1K – $15K |
| 2019-02-28 | John F Reed | sell | $1K – $15K |
| 2019-01-04 | Dean Phillips | buy | $1K – $15K |
| 2018-12-31 | James M Inhofe | sell | $15K – $50K |
| 2018-11-16 | James M Inhofe | sell | $15K – $50K |
| 2018-08-30 | ZOE LOFGREN | sell | $1K – $15K |
| 2018-07-12 | James M Inhofe | buy | $15K – $50K |
| 2018-04-09 | MIKE KELLY | buy | $1K – $15K |
| 2018-02-22 | James M Inhofe | buy | $50K – $100K |
| 2018-02-09 | ALAN S. LOWENTHAL | buy | $15K – $50K |
| 2018-01-17 | Pat Roberts | buy | $1K – $15K |
| 2018-01-11 | John F Reed | sell | $1K – $15K |
| 2018-01-08 | ALAN S. LOWENTHAL | sell | $838+ |
| 2017-12-08 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-11-02 | ALAN S. LOWENTHAL | sell | $1K – $15K |
| 2017-09-07 | Pat Roberts | sell | $1K – $15K |
| 2017-09-07 | Pat Roberts | sell | $15K – $50K |
| 2017-08-01 | Pat Roberts | buy | $15K – $50K |
| 2017-06-28 | MICHAEL T. MCCAUL | sell | $100K – $250K |
| 2017-06-15 | ZOE LOFGREN | buy | $1K – $15K |
| 2017-04-27 | Rohit Khanna | buy | $1K – $15K |
| 2017-04-06 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2017-02-21 | John F Reed | buy | $1K – $15K |
| 2017-02-20 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-02-15 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-01-25 | MICHAEL T. MCCAUL | sell | $15K – $50K |
| 2016-10-14 | ALAN S. LOWENTHAL | sell | $1K – $15K |
| 2016-10-14 | ALAN S. LOWENTHAL | sell | $1K – $15K |
| 2016-10-05 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-09-12 | K. Michael Conaway | sell | $1K – $15K |
| 2016-08-04 | K. Michael Conaway | buy | $1K – $15K |
| 2016-08-03 | MIKE KELLY | sell | $1K – $15K |
| 2016-08-03 | MIKE KELLY | sell | $1K – $15K |
| 2016-08-03 | K. Michael Conaway | buy | $1K – $15K |
| 2016-08-02 | MIKE KELLY | sell | $1K – $15K |
| 2016-08-01 | MIKE KELLY | sell | $1K – $15K |
| 2016-07-25 | John F Reed | buy | $1K – $15K |
| 2016-06-15 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-03-17 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2016-03-07 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2016-02-11 | John F Reed | buy | $1K – $15K |
| 2016-01-29 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-01-28 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2016-01-26 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2015-08-27 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-08-24 | MICHAEL T. MCCAUL | sell | $1K – $15K |